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Abstract
Background: Human infection with Wuchereria bancrofti causes a disabling parasitic disease known
as lymphatic filariasis, which is a major public health and socio-economic problem in many parts of
the world. At the onset of the study, little was known of the distribution of filariasis and its current
importance as a public health problem in Nepal.
Methods: Epidemiological mapping was undertaken to determine the prevalence of infection by
Wuchereria bancrofti in 37 districts of Nepal between July to December 2001. The study population
above 15 years of age was selected, and the immunochromatographic test (ICT Filariasis) was used
to screen for circulating filarial antigen (CFA).
Results: The overall prevalence of lymphatic filariasis from a 4,488-sample population was 13% and
33/37 districts were found to be endemic. On the basis of geographical data, the highest number
of cases was found at altitudes between 500–700 m; however, a substantial number of infected
individuals were found in the highly populated Kathmandu valley, at altitudes between 900–1,500
metres where transmission appears to take place. Prevalence rates above 20% were found in 11
districts (with the highest rate of 40%), 6–19% were found in 15 districts, and 0.1–5% were in 7
districts.
Information on people's knowledge, attitudes and behaviour towards filariasis was also collected by
means of a structured questionnaire, which is presented and discussed in the study.
Conclusions: This is the most extensive study of lymphatic filariasis undertaken to date in Nepal.
The study indicates that the prevalence of infection is far greater that was previously reported and
that lymphatic filariasis should be a much higher health priority than currently given.
Background
Lymphatic filariasis (LF) is disabling parasitic disease that
has been identified by the World Health Organization
(WHO) as a major public health problem with an increas-
ing prevalence worldwide [1]. At present, 1.1 billion peo-
ple (20% of the world's population) in some 80 endemic
countries located in tropical areas of the world are at risk
of infection by Wuchereria bancrofti and  Brugia malayi.
Over one third of the population at risk lives on the Indi-
an sub-continent with an estimated 45 million infected
individuals [2].
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Approximately one third of infected individuals present
with overt clinical manifestations: lymphoedema and el-
ephantiasis of the limbs or genitals, hydrocoele, chyluria,
pneumonitis, or recurrent infections associated with dam-
aged lymphatics; the remainder are at the pre-clinical
stage of infection (most often with microfilaria in their
blood). To this burden of disease, must also be added the
serious psychosocial consequences that these profoundly
disabling lesions often have. The disease is thought to be
caused primarily by adult worms living in the lymphatic
vessels; the microfilariae released by the female worms cir-
culate in the peripheral blood and are not harmful, but
can be ingested by mosquitoes, which transmit the infec-
tion from person to person.
Diagnosis of bancroftian filariasis relied until recently al-
most exclusively on the detection and identification of
microfilariae in night blood specimens [3,4]. The reason
for this is that, in most geographical areas, W. bancrofti mi-
crofilariae have a natural periodicity, with highest intensi-
ty in the peripheral blood at night and few or none during
the day [5]. The other alternative test is a DEC provocation
test, where the suspected patient is given a single oral dose
of 50–100 mg of diethylcarbamazine (DEC is a safe drug,
normally used for the treatment for LF), followed by a
blood sample 30–45 minutes later: this procedure can
"flush out" microfilaria into the peripheral blood during
day time and has a sensitivity that is almost comparable
to that of night blood surveys [6,7]. Tests based on detec-
tion of specific W. bancrofti circulating filarial antigen
(CFA) have been highly successful and a number of kits
have recently become commercially available. The high
specificity and sensitivity of the test has been confirmed in
a number of studies [8–10]. More recently, ICT Diagnos-
tics in Australia produced a simple immunochromato-
graphic card test (AMRAD ICT) for the detection of
circulating filarial antigen in serum and whole blood
specimens [10,11]. In this test, antigen capture is accom-
plished by a monoclonal antibody with high sensitivity
and specificity to adult W. bancrofti antigen [10]. The test
is rapid and requires no equipment, which makes it suita-
ble for use in many endemic areas in the developing
world. In Nepal, no national study on the prevalence and
distribution of lymphatic filariasis has been previously at-
tempted, apart from a limited epidemiological survey in
semi-urban areas of the central part of country [12–14],
which established that LF was endemic. We carried out a
study in different districts of Nepal to obtain baseline data
on the prevalence of filariasis using the immunochroma-
tographic test (ICT) for CFA detection together with a
questionnaire and a clinical evaluation of cases, as a pre-
liminary step for developing a strategy to eliminate lym-
phatic filariasis from Nepal.
Materials and Methods
Study design
Nepal is administratively subdivided into 75 districts, of
which 58 districts (20 districts are in the Terai region and
38 are hill districts) are potentially endemic for filariasis;
the 17 remaining districts are in mountainous regions and
unlikely to be endemic since transmission does not nor-
mally occur above 2,000 meters. This preliminary study
was designed to establish the approximate extent of the
lymphatic filariasis problem in Nepal and provide the jus-
tification for further investigation and eventually future
intervention programmes.
The study was undertaken over a period of 6 months from
July to December 2001 in 37 districts, selected from the 58
potentially endemic districts. Village development com-
mittees (VDCs) are the smallest administrative entity in
Nepal; we selected two or three VDCs for each district.
Random selection was not feasible in these communities.
The aim of the study was explained to the villagers and a
request was made for volunteers to come forward. Every
subject was informed of the purpose of the study and his
or her consent was obtained. The study was approved by
the Ethical and Research Committees of the Nepal Health
Research Council.
The survey consisted of a questionnaire and a blood sam-
ple for parasitological examination and CFA testing. We
aimed to select 100 volunteers over 15 years of age per
VDC; however, in view of the dispersed nature of most
communities tested, the study sample per VDC was usual-
ly reduced to 50–60 (hence the decision to test 2–3 VDCs
per district). Apart from the target age (above 15 years of
age in this study rather than school-age children), this
procedure is comparable to the Lot Quality Assurance
Sampling (LQAS) or the Rapid Geographical Assessment
of Bancroftian Filariasis (RAGFIL) used in other studies to
estimate endemicity [15–19].
Before blood sampling all individuals who participated
were interviewed, using a structured questionnaire, on
their knowledge, attitude and behaviour in relation to
filariasis. A record of age, sex, occupation, educational sta-
tus, medical history, birthplace, travel history, and use of
bednet/number of bed nets used in the household, was
kept. All participants were examined with the help of the
local health worker for signs of clinical filariasis i.e. el-
ephantiasis (lymphoedema), presence of non-pitting
oedema, scrotal swelling (hydrocele), breast swelling and
hand swelling.
Circulating filarial antigen screening
50–100 samples were tested from two or three VDCs from
each district using the ICT card; the total % of positive for
these samples was taken as the prevalence rate for thatFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/7
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district. Two technicians worked together in this survey:
one technician collected finger prick blood using a sterile
lancet and a capillary tube, which was filled up to the
mark of 100 µl; immediately after, the other technician
performed the ICT according to manufacturer's instruc-
tions. After the blood sample was taken, the participants
were asked to wait for the results. The ICT card was
checked after 10 minutes looking for two lines (C and T)
in the viewing window: any visible line in the T area indi-
cates a positive test result and the test was considered neg-
ative if only the C line appeared. The test was discarded as
invalid, and repeated, if either no lines appeared, or only
the T line appeared (i.e. without a C line).
Parasitological test
Whenever possible, night blood collections were made
from 23.00 PM- 2.00 AM. Sixty microliters of finger-
pricked blood were drawn for thick blood film, air dried,
then stained with Giemsa solution (dilution 1 in 20) for
15–20 minutes. The parasites were examined and counted
after returning to the laboratory [20] and results com-
pared to the ICT results.
DEC provocation test
Some patients in the study were given a single oral dose of
50 mg of diethylcarbamazine (DEC), followed by a 2nd
blood sample collection 30 minutes later. This procedure
enabled visualisation of parasites in situations where
night sampling was not acceptable and was used as quali-
ty control for the ICT. A thick blood film was prepared,
air-dried, stained and examined as for the parasitological
test.
Statistics
The data were analyzed by using SPSS 10.00 for entire
study http://www.spss.com/.
GIS study
A GPS record of the geographical location of all study ar-
eas was taken and will be used in future to analyse the top-
ographic distribution of lymphatic filariasis and develop
prediction maps. In this preliminary study, information
has been applied to a distribution of ICT positive cases in
relation to altitude.
Results
District-wise prevalence of lymphatic filariasis
The overall prevalence of lymphatic filariasis from a
4,488-sample population studied from 37 districts was
582 (13%); 33/37 districts were considered endemic on
the basis of this preliminary study. A distribution of anti-
genemia above 20% was found in 11 districts with the
highest rate of 40%, 6 to 19% were found in 15 districts,
0.1 to 5% were in 7 districts. Current categorization of en-
demicity level is shown in Figure 1, showing confirmed
filaria-endemic districts in RED and districts contiguous
to endemic districts but where endemicity was not con-
firmed in GREY; no study has yet been performed in the
districts in WHITE. Detailed ICT results district-by-district
are given on Table 1.
Age and sex-wise distribution of antigenaemia
The sample of 4,488 was made up of 2,576 males and
1,912 females. Although, the highest positivity of antige-
naemia was found among males (57.4%), the difference
between male and female was not statistically significant
(P > 0.005). Of the total 582 ICT-positive people, the
highest positive rate of 15.8% was found in the 46–50 age
group whereas the lowest (10%) was amongst individuals
in the 36–40 age group (Figure 2). Considering the size of
the sample, these differences are not significant.
Chronic clinical filariasis
The chronic conditions of lymphatic filariasis, namely el-
ephantiasis (lymphoedema) and hydrocele, were preva-
lent in the study population. Elephantiasis alone was
recorded in 94 males and 127 females. 71 males were af-
fected by more than one sequelae of lymphatic filariasis
(e.g. elephantiasis and hydrocele). Breast swelling and
hand swelling was also observed. While these figures are
an indication of a substantial disease burden in the com-
munities examined, they do not accurately reflect the level
of burden since the study was only performed on volun-
teers, rather than on a random survey basis.
Parasitology and DEC provocation test
A total of 268 samples were collected by night blood sam-
pling and DEC provocation test: 216 of these were ICT
positive and 52 were ICT negative. Both ICT positive and
negative samples were examined microscopically. A rate
of 38% microfilaria positivity was detected from amongst
the night blood of ICT positive samples and 57.4% micro-
filaria positivity was detected amongst the samples from
the DEC provocation test. All 52 ICT negative samples of
thick smears were also negative by microscopical exami-
nation. All night blood positive for microfilaria were also
found positive with DEC provocation test (Table 2).
Microfilaria density
The thick smear positive samples were counted for the lev-
el of microfilaria density. The microfilarial density was
classified in three levels as 1–10, 11–50 and > 50 micro-
filaria per 60 µl of thick blood film (Table 3)
Geographical origin (Birth place)
The respondents were asked about their birthplace, 84.4%
were local people and 15.6% had migrated from else-
where; filariasis prevalence was 12.4 % and 16.2% for lo-
cal and migrants, respectively. If the respondents were not
from the locality, questions were asked about their originFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/7
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and travel history within the year. Nearly 44% people said
that they had visited other places, mainly Terai/India
where they had spent at least one week. There was no sta-
tistically significant difference in ICT positivity between
the group who had a travel history and the group who did
not (P > 0.005).
Geographical distribution of lymphatic filariasis
There was little difference in ICT positivity between differ-
ent altitude classes: 13.8–14.0% positivity in classes be-
low 300 m, 300–500 and 700–900; the altitude class
500–700 is the one where there is the highest proportion
of positive in the ICT tested persons (16.5%) was found,
while the lowest positivity was in the 900–1,500 class
(9.6%). The geographical distribution of relative ICT pos-
itivity rates is illustrated on a GIS map of Nepal (Figure 3).
Treatment received for filariasis, leprosy and tuberculosis
Individuals taking part in the study were asked about tak-
ing anti-filarial drugs and 2.5% mentioned that they had
taken medicine whereas 97.5% replied negatively. Ques-
tions regarding treatment history for leprosy and tubercu-
losis (TB) within the previous two years indicated that
only 4% had been treated for TB or leprosy. The distribu-
tion of CFA amongst those who had been treated for TB or
leprosy and those not treated was found to be highly sig-
nificant (P < 0.005): ICT positivity was 13% (578/4,312)
amongst the people who did not receive any treatment for
TB or leprosy compared to only 2% (4/176) amongst
those who had received treatment recently.
Knowledge of lymphatic filariasis
During the study period, the sample population was
asked about their knowledge of lymphatic filariasis. Most
of the people recognized the signs of lymphatic filariasis
particularly elephantiasis by their social experience, but
they had inadequate knowledge of recognition of adenol-
ymphangitis (ADL), hydrocele, arm swelling and breast
swelling as a disease of lymphatic filariasis. Of the total re-
spondents (1,754 out of 4,488 individuals included in the
study), 49.3% said that filariasis was caused by mosquito
bites, 15% mentioned flies and insects, 5% blamed bad
weather, 5.6% blamed poor living status, 7.5% believed
that evil spirits were responsible and 9.6% did not know.
Figure 1
Administrative districts of Nepal, showing the extent of the mapping exercise. Districts found positive are coloured 
in red, districts found negative in grey.Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/7
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Treatment-seeking behaviour
In most rural areas, where people face many health prob-
lems, there is a general tendency to first consult the tradi-
tional healer, locally called "Dhami/Jhankri". In this
study, of a total of 4,488 respondents, 30% consulted tra-
ditional healer, 38% consulted modern medicine practi-
tioner (health assistant, doctor, nurse or private
practioners), 22% used herbal medicine for self-treatment
and 10% did not seek any treatment.
In answer to questions regarding other diseases, 2,625
(58.5%) replied that they were suffering from other
diseases.
Use of bed-nets
Of the total number of respondents, nearly 40% people
mentioned that they used bed-nets in their household.
Based on the questionnaire, there was no significant dif-
ference between bed-net users and non-users with regards
to the clinical signs of filarial disease, but higher ICT rates
were found among non bed-net users.
Discussion and conclusions
Lymphatic filariasis has been identified as a potentially
eradicable disease [18,21] and the 50th  World Health
Assembly 1997 passed a resolution that 'elimination of
lymphatic filariasis as a public health problem' should be
considered a priority by member states [18]. Delimitation
of endemic localities is an essential prerequisite for plan-
ning control or elimination programmes.
The present study, in different districts of Nepal, indicates
lymphatic filariasis constitutes a widespread public health
problem in the country. Out of a total of 37 districts stud-
ied, 11 districts were found to have a prevalence above
20%, the highest observed rate being 40%. The finding of
CFA positives (and clinical cases) in the Terai region (at an
altitude between 70 and 300 metres) was to be expected
in view of the rate of infection previously reported from
neighbouring districts of India (e.g. 13.8% positivity in
Northern Bihar) [22], but it is worth observing that the
prevalence rates found in Eastern Terai districts were gen-
erally much lower (negative in Saptari, Ilam and Mahotta-
Figure 2
Age-wise distribution of antigenaemia. Negative individuals in purple, positive cases in greyFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/7
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ri districts). Perhaps the most important finding in this
preliminary study was the high prevalence observed in hill
districts (the highest altitude tested was 1,400 metres),
which was not explained by migration of population from
Terai districts: this finding is important since Kathmandu
valley is the most populated area of Nepal and CFA prev-
alence was particularly high in the VDCs tested in that
area (e.g. 20% in Kathmandu and Bhaktapur, 26% in Ka-
vre). These findings are in keeping with Jung's survey [12],
which had indicated a prevalence of 25% in a small sam-
ple of the population and had identified Culex (Cx.) quin-
quefasciatus as the main vector in all the surveyed areas. A
small study conducted by Pradhan et al., [13] in Gokarna
VDC of Kathmandu valley reported more than 12% of mi-
crofilarial infection in the community and 12 species of
mosquitoes have been identified (i.e. Anopheles (A.) niger-
rimus, A, vagus, A. willmori, A. kessele, Culex (Cx.) fusco-
cephala, Cx. gelidus, Cx. psedovishnui, Cx. quinquefasciatus,
Cx. sinensis, Cx. vishuni, Cx. whitmori and Cx. tritaeniorhyn-
chus); in this study Cx. quinquefasciatus was also found to
be the predominant species. In another VDC of Kathman-
du valley (Tokha-Chandeshwori VDC), a night blood sur-
vey of 978 villagers showed a prevalence of 5.8%
microfilaria by thick blood films and 9.6% of villagers
were found to present clinical signs and symptoms of
filariasis [14]. It will be necessary, in further studies, to de-
fine the precise geographical limits of the endemic zone
(particularly the maximal altitude, since many of Nepal
districts are mountainous) and whether transmission oc-
curs in urban areas as well as rural areas. Others have sug-
gested that an increased prevalence of the disease may be
a consequence of changes in the demographic
characteristics of at-risk countries. Crowded living condi-
tions, housing quality, and inadequate waste disposal and
sanitation facilities combined with seasonal migration be-
tween endemic rural areas and non-endemic urban areas
have all been shown to contribute to the growing "urban-
ization" of the disease [23,24].
Lymphatic filariasis occurs in individuals of all ages and
both sexes but prevails in those of low socioeconomic sta-
tus [17]. As the chronic manifestations of lymphatic
filariasis appear most frequently later in life, clinical and
pathological investigations have focused on the adult
population. Our present study indicates that the preva-
lence of chronic forms of lymphatic filariasis is age-de-
pendent in both sexes, but generally higher in males than
in females. This observation is in keeping with similar
studies of chronic filarial conditions from South India
Figure 3
Geographical distribution of filariasis. Black dots indicate the site of testing and size of the dot is proportional to the per-
centage of prevalence. The GIS map is colour-graded with respect to altitude.Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/7
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[25,26] and Varanasi, North India [27,28]. Hydrocele was
the most frequent clinical sign, while elephantiasis of the
leg was comparatively rare.
In this study, the use of the ICT filariasis test for the detec-
tion of antigenaemia proved of high sensitivity and effi-
ciency. When ICT was compared to night blood samples
and day samples after DEC provocation, the results were
predictably twice as high as parasitology, in keeping with
published validation studies of ICT, which had shown
thick film to be of low sensitivity. The prevalence rates ob-
served need to be considered with caution because of the
non-random nature of the survey technique: while such
information is sufficient for defining endemicity of inter-
vention units, more accurate prevalence rates will need to
be determine in selected sentinel sites to be used for mon-
itoring future elimination programmes. It is of interest to
note that this survey has provided sufficient information
for advocacy purposes which has resulted in the publica-
tion of a National Programme for the Elimination of
Filariasis in Nepal in April 2002.
In the context of this preliminary survey, the finding of
significantly lower ICT rates in individuals receiving TB or
leprosy treatment (2% compared to 13% in non-treated
individuals) merits discussion in view of the recently de-
scribed relationship between Wolbachia  infection and
filarial survival [29]: long-term antibiotherapy, such as is
Table 1: District-wise prevalence of lymphatic filariasis in Nepal
Districts ICT-Positive (%) Total
Ilam 0 (0.0) 102
Jhapa 24 (24.0) 100
Morang 14 (13.6) 103
Sunsari 1 (1.0) 101
Udayapur 6 (4.0) 150
Siraha 5 (3.3) 152
Dhanusha 1 (0.7) 152
Mahottari 0 (0.0) 102
Sindhuli 7 (4.7) 150
Saptari 0 (0.0) 100
Rautahat 24 (19.0) 126
Kavre 26 (26.0) 100
Kathmandu 22 (20.0) 110
Lalitpur 0 (0.0) 100
Banke 21 (20.8) 101
Kailali 9 (6.0) 151
Kanchanpur 20 (20.0) 100
Bhaktapur 20 (19.8) 101
Kapilbastu 24 (24.0) 100
Makawanpur 17 (16.8) 101
Chitwan 19 (18.4) 103
Rupandehi 18 (17.6) 102
Dang 31 (29.8) 104
Nawalparasi 23 (22.8) 101
Dhading 22 (14.7) 150
Nuwakot 30 (29.4) 102
Surkhet 18 (17.3) 104
Doti 10 (6.7) 150
Dadeldhura 10 (6.5) 153
Bardiya 41 (39.8) 103
Palpa 3 (2.0) 152
Kaski 11 (7.3) 150
Syanja 22 (14.7) 150
Gorkha 20 (19.6) 102
Tanahu 24 (16.0) 150
Parsa 32 (20.3) 158
Dhankuta 7 (4.6) 152
Total 582 (13.0) 4488
Note: Figures in parenthesis indicate percentagesFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/7
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given for the treatment of tuberculosis, would be the sort
of intervention needed to eliminate adult worms by de-
stroying their Wolbachia symbionts. The observation of
significantly higher ICT rates in households not using
bed-nets is also noteworthy. Both observations emphasize
the need for further studies looking at possible interac-
tions and cross-benefits between different national inter-
vention programmes.
Authors' Contributions
M. Hommel and J.B. Sherchand designed the study, ana-
lyzed the data and wrote the first draft of the manuscript.
G.D. Thakur provided advise and logistical support to the
fieldwork. J. B. Sherchand organized and conducted the
work in the field. V. Obsomer advised on geographical is-
sues, transferred the field data to GIS and produced the
map. All authors contributed to the writing and editing of
the manuscript.
Competing interests
None declared
Acknowledgements
We are grateful to the Liverpool Lymphatic Filariasis Support Centre http:/
/www.filariasis.org.uk/ for funding the study, the WHO Filariasis Pro-
gramme http://www.filariasis.org/ for providing the ICT tests, Dr. Mahen-
dra B. Bista ex. Director of Ministry of Health Epidemiology and Disease 
Control Division Nepal for his support and encouragement during field 
study activities. We thank our staff of the Infectious and Tropical Disease 
Research and Prevention Centre/ Nepal: Mr. Biswa Kafle, Mrs. Sarala Sher-
chand, Mrs. Bishnu Thakali, Mr. Ashok Chaudhary, Mr. Govinda Gurung, 
Mr. Jaya Singh Badal, Dr. Dirgh Singh Bam, Dr. Shushil K. Shakya and all dis-
tricts health officers, VDCs chairman of study areas of Nepal.
References
1. WHO Lymphatic filariasis: the disease and its control. World
Health Organization Geneva: Technical Report Series 1992, 821:1-71
2. Michael E, Bundy DAP and Grenfell BT Re-assessing the global
prevalence and distribution of lymphatic filariasis. Parasitology
1996, 112:409-428
3. McMahon JE, Magayauka SA, Kolstrup N, Mosha FW, Bushrod FM,
Abaru DE and Bryan JH Studies on the transmission and preva-
lence of Bancroftian filariasis in four castal villages of
Tanzania. Ann Trop Med Parasitol 1981, 75:415-431
4. Nicolas L New tools for diagnosis and monitoring of bancrof-
tian filariasis parasitism: the Polynesian experience. Parasitol
Today 1997, 13:370-375
5. Simonsen PE and Meyrowitsch DW Bancroftian filariasis in Tan-
zania: species antibody responses in relation to long-term
observations on microfilaremia.  Am J Trop Med Hyg 1998,
59:667-672
6. Sasa M, Oshima T, Sato K., Mitsui G, Sugata F, Nishi S, Yamamoto H,
Tada I and Motoi E Studies on epidemiology and control of
filariasis: observations on the carriers of Wuchereria bancrofti
in the Arami islands with special reference to the effects and
side reactions of diethylcarbamazine.  Jap J Exp Med 1963,
33:213-243
7. Manson-Bahr PEC and Wijers DJB The effect of a small dose of
diethylcarbamazine on the circulation of microfilariae of
Wuchereria bancrofti. Trans R Soc Trop Med Hyg 1972, 66:18
8. More SJ and Copeman DB A highly specific and sensitive mono-
clonal antibody-based ELISA for the detection of circulating
antigen in bancroftian filariasis. Trop Med Parasitol 1990, 41:403-
406
9. Chanteau S, Glazious P, Plichart C, Luquiaud P, Mouliapelat JP, Nguy-
en L and Cartel JL Wuchereria bancrofti filariasis in French Poly-
nesia: age-specific patterns of microfilaremia, circulating
antigen, and specific IgG and IgG4 responses according to
transmission level. Int J Parasitol 1995, 25:81-85
10. Weil GJ, Lammie PJ and Weiss N The ICT Filariasis Test: A rap-
id-format antigen test for diagnosis of bancroftian filariasis.
Parasitol Today 1997, 13:401-404
11. Phantana S, Sensathein S, Songtrus J, Klagrathoke S and Phongnin K
ICT Filariasis test: A new screening test for bancroftian
filariasis. Southeast Asian J Trop Med Public Health 1999, 30:47-51
12. Jung RK A brief study on the epidemiology of filariasis in
Nepal. Journal Nepal Medical Association 1973, 11:5-6
13. Pradhan SP, Shrestha I, Palikhey N and Uprety RP Epidemiological
study of lymphatic filariasis in Gokarna village development
committee of Kathmandu valley during August and Septem-
ber, 1997. J Nepal Hlth Res Council 1998, 2:13-17
14. Bhusal KP, Joshi AB, Mishra PN and Bhusal K Prevalence of
Wuchereria bancrofti infections in Tokha-Chandeshwori
Village Development Committee, Kathmandu, Nepal. J Insti-
tute Med 2000, 22:13-19
Table 2: Distribution of microfilaria among different samples
Parasitological Examination
Description of samples Thick smear- DEC provocation test Thick smear-night blood examination: (at 23:00 to 2.00 AM)
ICT positive samples (n = 216) 124 (57.4%) 82 (38%)
ICT negative samples (n = 52) 0 0
Total samples (n = 268) 124 82
Table 3: The number of positives in ICT according to density of microfilariae as determined by thick blood film.
Density of microfilariae
MF density 0 1–10 11–50 >50 Total
ICT positive 92 81 32 11 216Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/7
Page 9 of 9
(page number not for citation purposes)
15. Gyapong JO, Kyelem D, Kleinschmidt I, Agbo K, Ahouandogbo F,
Gaba J, Owusu-Banahene G, Sanou S, Sodahlon YK, Biswas G, Kale
OO, Molyneux DH, Roungou JB, Thomson MC and Remme J The
use of spatial analysis in mapping the distribution of bancrof-
tian filariasis in four West African countries. Ann Trop Med
Parasitol 2002, 96:695-705
16. Gyapong JW, Adjei S, Gyapong M and Asamoah G Rapid commu-
nity diagnosis of lymphatic filariasis. Acta Trop 1996, 61:65-74
17. Ottesen EA, Duke BOL, Karam M and Behbehani K Strategies and
tools for the control/ elimination of lymphatic filariasis. Bull
World Health Organ 1997, 75:491-503
18. WHO Lymphatic filariasis: reasons for hope. Geneva: World
Health Organization 1997. WHO/CTD/FIL/97.4 1997, 
19. Srividya A, Lall R, Ramaiah KD, Hoti SL, Pani SP and Das PK Devel-
opment of rapid assessment procedures for the delimitation
of lymphatic filariasis-endemic areas. Trop Med Int Health 2000,
5:64-71
20. Denham DA, Dennis DT, Ponnodurai T, Nelson GS and Guy F Com-
parison of a counting chamber and thick blood smear meth-
ods of counting microfilariae. Trans R Soc Trop Med Hyg 1971,
65:521-526
21. Centre for Disease Control Recommendations of the Interna-
tional Task Force for Disease Eradication. Morb Mortal Wkly
Rep 1993, 42:1-38
22. Sabesan S, Palaniyandi M, Das PK and Michael E Mapping of lym-
phatic filariasis in India. Ann Trop Med Parasitol 2000, 94:591-606
23. Schweinfurth U Filarial disease in Ceylon: a geographical and
historical analysis. Ecology and Disease 1983, 2:309-319
24. Mak JW Problems in filariasis control and the need for human
behaviour and socio-economic research. Southeast Asian J Trop
Med Public Health 1986, 17:479-485
25. Pani SP, Balakrishnan N, Srividya A, Bundy DAP and Grenfell BT Clin-
ical epidemiology of bancroftian filariasis: effect of age and
gender. Trans R Soc Trop Med Hyg 1991, 85:260-264
26. Ramaiah KD, Ramu K, Vijaykumar KN and Guyatt H Epidemiology
of acute filarial episodes caused by Wuchereria bancrofti in-
fection in two rural villages in Tamil Nandu, South India.
Trans R Soc Trop Med Hyg 1996, 90:639-642
27. Sharma S, Sharma M and Rathur S Bancroftian filariasis in the
Varanasi region of north India: an epidemiological study. Ann
Trop Med Parasitol 1999, 93:379-387
28. Babu BV, Acharya AS, Mallick G, Jangid PK, Nayak AN and Satyanaray-
an K Lymphatic filariasis in Khurda district of Orissa India: An
epidemiological study. Southeast Asian J Trop Med Public Health
2001, 32:240-243
29. Taylor MJ Elimination of lymphatic filariasis as a public health
problem: Wolbachia bacteria of filarial nematodes in the
pathogenesis of disease and as a target for control. Trans R Soc
Trop Med Hyg 2000, 94:596-598